{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:28:15Z","timestamp":1783016895349,"version":"3.54.6"},"reference-count":106,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009553","name":"Agentura Pro Zdravotnick\u00fd V\u00fdzkum \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NU23-06-00045"],"award-info":[{"award-number":["NU23-06-00045"]}],"id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.tem.2023.07.005","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T08:05:36Z","timestamp":1692000336000},"page":"640-651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Diabetes in stiff-person syndrome"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0703-951X","authenticated-orcid":false,"given":"Petr","family":"Heneberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2023.07.005_bb0005","first-page":"421","article-title":"Progressive fluctuating muscular rigidity and spasm (\u201cstiff-man\u201d syndrome): report of a case and some observations in 13 other cases","volume":"31","author":"Moersch","year":"1956","journal-title":"Proc. Staff Meet. Mayo Clin."},{"key":"10.1016\/j.tem.2023.07.005_bb0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11940-009-0013-9","article-title":"Stiff person syndrome: advances in pathogenesis and therapeutic interventions","volume":"11","author":"Dalakas","year":"2009","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.tem.2023.07.005_bb0015","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/mus.20653","article-title":"Rigidity and spasms from autoimmune encephalomyelopathies: stiff-person syndrome","volume":"34","author":"Espay","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.tem.2023.07.005_bb0020","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJM198804213181602","article-title":"Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus","volume":"318","author":"Solimena","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2023.07.005_bb0025","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archneurol.2011.991","article-title":"Stiff-man syndrome and variants: clinical course, treatments, and outcomes","volume":"69","author":"McKeon","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.tem.2023.07.005_bb0030","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1212\/WNL.41.10.1588","article-title":"Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome","volume":"41","author":"Brashear","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.tem.2023.07.005_bb0035","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa01167","article-title":"High-dose intravenous immune globulin for stiff-person syndrome","volume":"345","author":"Dalakas","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2023.07.005_bb0040","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1084\/jem.180.2.595","article-title":"Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus","volume":"180","author":"Kim","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tem.2023.07.005_bb0045","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0025-6196(12)61012-X","article-title":"Stiff-man syndrome","volume":"66","author":"McEvoy","year":"1991","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.tem.2023.07.005_bb0050","series-title":"Motor unit hyperactivity states","first-page":"45","article-title":"Stiff-man syndrome: clinical aspects and anti-islet cell antibodies as a disease marker","author":"McEvoy","year":"1993"},{"key":"10.1016\/j.tem.2023.07.005_bb0055","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJM199005313222202","article-title":"Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome","volume":"322","author":"Solimena","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2023.07.005_bb0060","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJM198906013202220","article-title":"Plasmapheresis in the treatment of stiff-man syndrome","volume":"320","author":"Vicari","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2023.07.005_bb0065","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ana.410080212","article-title":"Congenital stiff-man syndrome","volume":"8","author":"Sander","year":"1980","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tem.2023.07.005_bb0070","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJM199302253280805","article-title":"Autoantibodies to a 128-kDa synaptic protein in three women with the stiff-man syndrome and breast cancer","volume":"328","author":"Folli","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2023.07.005_bb0075","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1084\/jem.178.6.2219","article-title":"The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of stiff-man syndrome with breast cancer","volume":"178","author":"De Camilli","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tem.2023.07.005_bb0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1212\/WNL.64.2.399-a","article-title":"Stiff person syndrome does not always occur with maternal passive transfer of GAD65 antibodies","volume":"64","author":"Burns","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.tem.2023.07.005_bb0085","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: standards of care in diabetes \u2013 2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2023.07.005_bb0090","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1212\/01.WNL.0000145836.72059.3B","article-title":"Glutamic acid decarboxylase autoimmunity in Batten disease and other disorders","volume":"63","author":"Pearce","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.tem.2023.07.005_bb0095","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1212\/01.WNL.0000145661.01675.A8","article-title":"Markedly elevated GAD antibodies in SPS: effects of age and illness duration","volume":"63","author":"Murinson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.tem.2023.07.005_bb0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/08916939708994729","article-title":"Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome","volume":"25","author":"Morgenthaler","year":"1997","journal-title":"Autoimmunity"},{"key":"10.1016\/j.tem.2023.07.005_bb0105","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.4065\/73.12.1161","article-title":"Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus","volume":"73","author":"Walikonis","year":"1998","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.tem.2023.07.005_bb0110","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s11606-019-04835-9","article-title":"Stiff person syndrome and type 1 diabetes mellitus: a case of the chicken or the egg?","volume":"34","author":"Rathbun","year":"2019","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.tem.2023.07.005_bb0115","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Sa\u00edz","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.tem.2023.07.005_bb0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/cei.12026","article-title":"Characteristics of in vitro phenotypes of glutamic acid decarboxylase 65 autoantibodies in high-titre individuals","volume":"171","author":"Ch\u00e9ramy","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tem.2023.07.005_bb0125","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jnnp-2014-309201","article-title":"Stiff-person syndrome: insights into a complex autoimmune disorder","volume":"86","author":"Baizabal-Carvallo","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.tem.2023.07.005_bb0130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0896-6273(91)90077-D","article-title":"Two genes encode distinct glutamate decarboxylases","volume":"7","author":"Erlander","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.tem.2023.07.005_bb0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2011.05.005","article-title":"Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies","volume":"37","author":"Ali","year":"2011","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.tem.2023.07.005_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018411","article-title":"An analysis of the cross-reactivity of autoantibodies to GAD65 and GAD67 in diabetes","volume":"6","author":"Jayakrishnan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tem.2023.07.005_bb0145","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00125-004-1495-3","article-title":"Conformation-dependent GAD65 autoantibodies in diabetes","volume":"47","author":"Luo","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2023.07.005_bb0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11892-016-0738-2","article-title":"Islet autoantibodies","volume":"16","author":"Lampasona","year":"2016","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.tem.2023.07.005_bb0155","doi-asserted-by":"crossref","first-page":"7755","DOI":"10.4049\/jimmunol.175.11.7755","article-title":"Analysis of GAD65 autoantibodies in stiff-person syndrome patients","volume":"175","author":"Raju","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.tem.2023.07.005_bb0160","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.410440209","article-title":"Inhibition of \u03b3-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome","volume":"44","author":"Dinkel","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tem.2023.07.005_bb0165","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4049\/jimmunol.156.2.818","article-title":"Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition","volume":"156","author":"Daw","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.tem.2023.07.005_bb0170","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1073\/pnas.90.7.2832","article-title":"Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase","volume":"90","author":"Richter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2023.07.005_bb0175","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.2337\/db06-1715","article-title":"GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes","volume":"56","author":"Mayr","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2023.07.005_bb0180","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1007\/s00125-014-3294-9","article-title":"GAD autantibody affinity in schoolchildren from the general population","volume":"57","author":"Bender","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2023.07.005_bb0185","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0168-8227(98)00072-2","article-title":"Severe insulin resistance in a patient with type 1 diabetes and stiff-man syndrome treated with insulin lispro","volume":"41","author":"Hirsch","year":"1998","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.tem.2023.07.005_bb0190","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jnnp.65.2.204","article-title":"Humoral and cellular immune parameters before and during immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus","volume":"65","author":"Hummel","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.tem.2023.07.005_bb0195","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.2337\/dc14-1444","article-title":"Latent autoimmune diabetes in stiff-person syndrome","volume":"37","author":"Fourlanos","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2023.07.005_bb0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1464-5491.2008.02605.x","article-title":"Insulin treatment in a patient with type 2 diabetes and stiff-person syndrome","volume":"26","author":"Weitgasser","year":"2009","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2023.07.005_bb0205","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.12998\/wjcc.v7.i19.2942","article-title":"Association of stiff-person syndrome with autoimmune endocrine diseases","volume":"7","author":"Lee","year":"2019","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.tem.2023.07.005_bb0210","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ncl.2012.09.005","article-title":"Stiff person syndrome","volume":"31","author":"Ciccoto","year":"2013","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.tem.2023.07.005_bb0215","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/1529-0131(199907)42:7<1312::AID-ANR2>3.0.CO;2-W","article-title":"Stiff-man syndrome: from the bedside to the bench","volume":"42","author":"Helfgott","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.tem.2023.07.005_bb0220","first-page":"261","article-title":"Stiff person syndrome: a tough and rigid case","volume":"17","author":"Liran","year":"2015","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.tem.2023.07.005_bb0225","doi-asserted-by":"crossref","DOI":"10.5334\/tohm.479","article-title":"A case of treatment resistance and complications in a patient with stiff person syndrome and cerebellar ataxia","author":"Jones","year":"2019","journal-title":"Tremor Other Hyperkinet. Mov. (N. Y.)"},{"key":"10.1016\/j.tem.2023.07.005_bb0230","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s13300-019-00729-5","article-title":"Insulin resistance in type 1 diabetes mellitus and its association with patient\u2019s micro- and macrovascular complications, sex hormones, and other clinical data","volume":"11","author":"\u0160imonien\u0117","year":"2020","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.tem.2023.07.005_bb0235","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5152\/eurasianjmed.2022.21039","article-title":"Prevalence of insulin resistance in type 1 diabetes mellitus and its correlation with metabolic parameters: the double trouble","volume":"54","author":"Pathak","year":"2022","journal-title":"Eurasian J. Med."},{"key":"10.1016\/j.tem.2023.07.005_bb0240","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12902-020-00570-z","article-title":"Comparison of indirect markers of insulin resistance in adult patients with double diabetes","volume":"20","author":"Ferreira-Hermosillo","year":"2020","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.tem.2023.07.005_bb0245","first-page":"1550","article-title":"Association of HLA-DQB1*0201 with stiff-man syndrome","volume":"77","author":"Pugliese","year":"1993","journal-title":"J. Clin. Endocrinol."},{"key":"10.1016\/j.tem.2023.07.005_bb0250","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/brain\/awac119","article-title":"A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 antibodies","volume":"146","author":"Strippel","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.tem.2023.07.005_bb0255","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3389\/fendo.2020.00594","article-title":"Exogenous insulin injection-induced stiff-person syndrome in a patient with latent autoimmune diabetes: a case report and literature review","volume":"11","author":"Lee","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.tem.2023.07.005_bb0260","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.2337\/diab.43.10.1254","article-title":"Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity","volume":"43","author":"Christie","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2023.07.005_bb0265","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0165-5728(96)00104-X","article-title":"The insulin-dependent diabetes mellitus-associated ICA 105 autoantigen in stiff-man syndrome patients","volume":"69","author":"Martino","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.tem.2023.07.005_bb0270","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2249.2006.03178.x","article-title":"Longitudinal epitope analysis of insulin-binding antibodies in type 1 diabetes","volume":"146","author":"Hall","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tem.2023.07.005_bb0275","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2337\/diabetes.47.5.733","article-title":"Definition of multiple ICA512\/phogrin autoantibody epitopes and detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes","volume":"47","author":"Kawasaki","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2023.07.005_bb0280","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11912-021-01089-9","article-title":"Rare adverse events with programmed death-1 and programmed death-1 ligand inhibitors: justification and rationale for a systematic review","volume":"23","author":"Smith","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.tem.2023.07.005_bb0285","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s00262-020-02699-1","article-title":"Autoimmune polyendocrine syndrome induced by immune checkpoint inhibitors: a systematic review","volume":"70","author":"Zhao","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.tem.2023.07.005_bb0290","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2337\/dbi18-0002","article-title":"Collateral damage: insulin-dependent diabetes induced with checkpoint inhibitors","volume":"67","author":"Stamatouli","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2023.07.005_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2369-1-1","article-title":"Early peri-operative hyperglycaemia and renal allograft rejection in patients without diabetes","volume":"1","author":"Thomas","year":"2000","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.tem.2023.07.005_bb0300","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2215\/CJN.05471008","article-title":"Hyperglycemia during the immediate period after kidney transplantation","volume":"4","author":"Chakkera","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2023.07.005_bb0305","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.amjcard.2019.10.054","article-title":"Incidence, risk factors, and trends for postheart transplantation diabetes mellitus","volume":"125","author":"Munshi","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.tem.2023.07.005_bb0310","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1097\/TP.0b013e3182347ea4","article-title":"Sitagliptin therapy in kidney transplant recipients with new-onset diabetes after transplantation","volume":"92","author":"Lane","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.tem.2023.07.005_bb0315","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1111\/j.1464-5491.2012.03676.x","article-title":"Diabetes before and after lung transplantation in patients with cystic fibrosis and other lung diseases","volume":"29","author":"Belle-van Meerkerk","year":"2012","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2023.07.005_bb0320","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1464-5491.2000.00206.x","article-title":"Predicting the occurrence of diabetes mellitus in recipients of heart transplants","volume":"17","author":"Depczynski","year":"2000","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2023.07.005_bb0325","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/152692480901900403","article-title":"Effects of hyperglycemia on the development of new-onset diabetes after liver transplantation","volume":"19","author":"Anderson","year":"2009","journal-title":"Prog. Transplant."},{"key":"10.1016\/j.tem.2023.07.005_bb0330","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1600-6143.2011.03855.x","article-title":"New-onset diabetes after kidney transplantation \u2013 changes and challenges","volume":"12","author":"Yates","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.tem.2023.07.005_bb0335","first-page":"125","article-title":"A study of steroid-induced diabetes mellitus in leprosy","volume":"81","author":"Papang","year":"2009","journal-title":"Indian J. Lepr."},{"key":"10.1016\/j.tem.2023.07.005_bb0340","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/0961203311402246","article-title":"Glucocorticoid-induced diabetes mellitus in patients with systemic lupus erythematosus treated with high-dose glucocorticoid therapy","volume":"20","author":"Ha","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.tem.2023.07.005_bb0345","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.tem.2011.09.001","article-title":"Diabetes in Cushing syndrome: basic and clinical aspects","volume":"22","author":"Mazziotti","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.07.005_bb0350","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archinte.1994.00420010131015","article-title":"Glucocorticoids and the risk for initiation of hypoglycemic therapy","volume":"154","author":"Gurwitz","year":"1994","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.tem.2023.07.005_bb0355","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/dmrr.2486","article-title":"Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment","volume":"30","author":"Hwang","year":"2014","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.tem.2023.07.005_bb0360","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0026-0495(83)90031-8","article-title":"Insulin release after acute hydrocortisone treatment in mice","volume":"32","author":"Longano","year":"1983","journal-title":"Metabolism"},{"key":"10.1016\/j.tem.2023.07.005_bb0365","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1172\/JCI119175","article-title":"Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets","volume":"99","author":"Lambillotte","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2023.07.005_bb0370","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/diabetes.54.4.1090","article-title":"Serum- and glucocorticoid-inducible kinase (SGK1) mediates glucocorticoid-induced inhibition of insulin secretion","volume":"54","author":"Ullrich","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2023.07.005_bb0375","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41419-021-04419-8","article-title":"Underlying mechanisms of glucocorticoid-induced \u03b2-cell death and dysfunction: a new role for glycogen synthase kinase 3","volume":"12","author":"Delangre","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tem.2023.07.005_bb0380","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cytogfr.2007.01.005","article-title":"Glucocorticoids in the regulation of transcription factors that control cytokine synthesis","volume":"18","author":"Liberman","year":"2007","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.tem.2023.07.005_bb0385","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.4049\/jimmunol.156.7.2406","article-title":"Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro","volume":"156","author":"Ram\u00edrez","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.tem.2023.07.005_bb0390","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41577-020-00464-0","article-title":"Glucocorticoids in T cell development, differentiation and function","volume":"21","author":"Taves","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tem.2023.07.005_bb0395","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.4049\/jimmunol.164.4.1768","article-title":"Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes","volume":"164","author":"Franchimont","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.tem.2023.07.005_bb0400","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/rr39","article-title":"Th2 cytokines and asthma: an introduction","volume":"2","author":"Barnes","year":"2001","journal-title":"Respir. Res."},{"key":"10.1016\/j.tem.2023.07.005_bb0405","series-title":"Translational autoimmunity. Volume 1. Etiology of autoimmune diseases","first-page":"61","article-title":"Role of Th1 and Th2 in autoimmunity","author":"Ramponi","year":"2022"},{"key":"10.1016\/j.tem.2023.07.005_bb0410","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010463","article-title":"Immunological markers as predictors of developing steroid-induced diabetes mellitus in pemphigus vulgaris patients. An observational study","volume":"97","author":"D\u0103nescu","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.tem.2023.07.005_bb0415","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bjd.13433","article-title":"Identification of a new disease cluster of pemphigus vulgaris with autoimmune thyroid disease, rheumatoid arthritis, and type I diabetes","volume":"172","author":"Parameswaran","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.tem.2023.07.005_bb0420","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-4632.2006.03044.x","article-title":"Epidemiologic survey of pemphigus vulgaris with oral manifestations in northern Greece: retrospective study of 129 patients","volume":"46","author":"Michalidou","year":"2007","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.tem.2023.07.005_bb0425","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11428-016-0070-0","article-title":"Glukokortikoide und Diabetes","volume":"12","author":"Willms","year":"2016","journal-title":"Diabetologe"},{"key":"10.1016\/j.tem.2023.07.005_bb0430","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/acr.21796","article-title":"Prevalence of oral glucocorticoid usage in the United States: a general population perspective","volume":"65","author":"Overman","year":"2013","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.tem.2023.07.005_bb0435","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4158\/EP08331.RAR","article-title":"Glucocorticoid-induced hyperglycemia","volume":"15","author":"Clore","year":"2009","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.tem.2023.07.005_bb0440","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s15006-014-3692-4","article-title":"Stoffwechselentgleisung bei Steroiddiabetes","volume":"156","author":"Siegmund","year":"2014","journal-title":"MMW Fortschr. Med."},{"key":"10.1016\/j.tem.2023.07.005_bb0445","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000365892","article-title":"Hyperglycemia induced by glucocorticoids in nondiabetic patients: a meta-analysis","volume":"65","author":"Liu","year":"2014","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.tem.2023.07.005_bb0450","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1210\/jcem-54-1-131","article-title":"Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action","volume":"54","author":"Rizza","year":"1982","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.07.005_bb0455","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1475-097X.1995.tb00514.x","article-title":"Effects of glucocorticoids and sympathomimetic agents on basal and insulin-stimulated glucose metabolism","volume":"15","author":"Paquot","year":"1995","journal-title":"Clin. Physiol."},{"key":"10.1016\/j.tem.2023.07.005_bb0460","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1592\/phco.24.5.508.33355","article-title":"Steroid-induced diabetes mellitus and related risk factors in patients with neurologic diseases","volume":"24","author":"Iwamoto","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.tem.2023.07.005_bb0465","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2337\/diacare.24.12.2023","article-title":"Plasma glucose levels throughout the day and HbA1c interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control","volume":"24","author":"Bonora","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2023.07.005_bb0470","doi-asserted-by":"crossref","DOI":"10.5402\/2012\/910905","article-title":"Steroid-induced diabetes: is it just unmasking of type 2 diabetes?","volume":"2012","author":"Simmons","year":"2012","journal-title":"ISRN Endocrinol."},{"key":"10.1016\/j.tem.2023.07.005_bb0475","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2018.01.047","article-title":"GABA dramatically improves glucose tolerance in streptozotocin-induced diabetic rats fed with high-fat diet","volume":"826","author":"Sohrabipour","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tem.2023.07.005_bb0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025338","article-title":"Oral treatment with \u03b3-aminobutyric acid improves glucose tolerance and insulin sensitivity by inhibiting inflammation in high fat diet-fed mice","volume":"6","author":"Tian","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tem.2023.07.005_bb0485","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.molimm.2005.07.025","article-title":"Human peripheral blood mononuclear cells express GABAA receptor subunits","volume":"43","author":"Alam","year":"2006","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.tem.2023.07.005_bb0490","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/TP.0b013e31829c24be","article-title":"GABA protects human islet cells against the deleterious effects of immunosuppressive drugs and exerts immunoinhibitory effects alone","volume":"96","author":"Prud\u2019homme, G.","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.tem.2023.07.005_bb0495","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.4049\/jimmunol.173.8.5298","article-title":"Gamma-aminobutyric acid inhibits T cell autoimmunity and the development of inflammatory responses in a mouse type 1 diabetes model","volume":"173","author":"Tian","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.tem.2023.07.005_bb0500","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/acn3.51486","article-title":"Impact of T cells on neurodegeneration in anti-GAD65 limbic encephalitis","volume":"8","author":"Dik","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.tem.2023.07.005_bb0505","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.tem.2023.07.005_bb0510","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/brain\/awac404","article-title":"Temporal lobe epilepsy with GAD antibodies: neurons killed by T cells not by complement membrane attack complex","volume":"146","author":"Tr\u00f6scher","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.tem.2023.07.005_bb0515","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00401-022-02448-x","article-title":"Complement activation contributes to GAD antibody-associated encephalitis","volume":"144","author":"Chuquisana","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tem.2023.07.005_bb0520","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41582-020-0359-x","article-title":"GAD antibodies in neurological disorders \u2013 insights and challenges","volume":"16","author":"Graus","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tem.2023.07.005_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120540","article-title":"Glutamic acid decarboxylase antibody-associated neurological syndromes: clinical and antibody characteristics and therapy response","volume":"445","author":"Madlener","year":"2023","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.tem.2023.07.005_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577915","article-title":"Stiff person syndrome spectrum disorders; more than meets the eye","volume":"369","author":"Newsome","year":"2022","journal-title":"J. Neuroimmunol."}],"container-title":["Trends in Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276023001480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276023001480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:45:19Z","timestamp":1760906719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276023001480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":106,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1043276023001480"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2023.07.005","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes in stiff-person syndrome","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2023.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}